Universal reference book for medicines
Name of the drug: NAFTIZIN (NAPHTHYZIN)

Active substance: naphazoline

Type: Vasoconstrictive drug for topical application in ENT practice

Manufacturer: СЛАВЯНСКАЯ АПТЕКА (Россия)
Description of the active substance:
This information is a reference and it is not enough that the drug has been prescribed by a doctor ..

PHARMACHOLOGIC EFFECT
Alpha-adrenomimetic.
When applied to mucous membranes it has a rapid, pronounced and prolonged vasoconstrictive effect.
INDICATIONS
Acute rhinitis, hay fever, acute and chronic laryngitis, acute eustachiitis, allergic and laryngeal edema associated with irradiation, hyperemia of the mucous membranes after operations in the upper respiratory tract, chronic conjunctivitis, asthenopic disorders, as an additional remedy for conjunctivitis of bacterial origin, in the treatment of urolithiasis , in combination with local anesthetics (with contraindications for the use of epinephrine).

DOSING MODE
Individual, depending on the indications and the dosage form used.

SIDE EFFECT
Local reactions: irritation of the mucosa (depending on the site of application);
when used for more than 1 week - swelling of the mucous membrane, atrophic rhinitis.
From the cardiovascular system: reactive hyperemia, tachycardia, increased blood pressure.

From the side of the central nervous system: a headache.

From the side of the digestive system: nausea.

CONTRAINDICATIONS
Children under 1 year old, arterial hypertension, hyperthyroidism, hypersensitivity to nafazoline, severe atherosclerosis, chronic rhinitis, severe eye diseases, diabetes mellitus;
simultaneous administration of MAO inhibitors and a period of up to 14 days after the end of their use.
PREGNANCY AND LACTATION
The use of nafazoline during pregnancy and lactation (breastfeeding) is possible only on strict indications when the expected therapeutic effect for the mother exceeds the potential risk of side effects in the fetus or child.

APPLICATION FOR CHILDREN
Contraindicated in children under 1 year.

SPECIAL INSTRUCTIONS
Nafazoline can have a resorptive effect.

With prolonged use, the severity of the vasoconstrictor effect gradually decreases (the phenomenon of tachyphylaxis), and in this connection it is recommended to take a break for several days after 5-7 days of use.

DRUG INTERACTION
Do not use simultaneously with MAO inhibitors or within 14 days after the end of their use.

Nafazoline slows the absorption of local anesthetics (prolongs their effect in the conduct of surface anesthesia).

Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!